| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0960-894X(01)00034-8 |
| P698 | PubMed publication ID | 11266171 |
| P2093 | author name string | Page KM | |
| McLay IM | |||
| Halley F | |||
| Maslen C | |||
| Redford EJ | |||
| Souness JE | |||
| Foster ML | |||
| Collis AJ | |||
| Wilsher NE | |||
| P2860 | cites work | A protein kinase involved in the regulation of inflammatory cytokine biosynthesis | Q24311139 |
| Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q28842973 | ||
| Computational methods for the prediction of 'drug-likeness' | Q33826560 | ||
| Molecular and cellular interactions in rheumatoid synovium. | Q40940390 | ||
| Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes. | Q42537136 | ||
| The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy | Q43542785 | ||
| Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis | Q73374754 | ||
| Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase | Q77906539 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 693-696 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
| P1476 | title | RPR203494 a pyrimidine analogue of the p38 inhibitor RPR200765A with an improved in vitro potency | |
| P478 | volume | 11 |
| Q50960105 | DMSO/I2 mediated C-C bond cleavage of α-ketoaldehydes followed by C-O bond formation: a metal-free approach for one-pot esterification. |
| Q78881129 | Imidazopyrimidines, potent inhibitors of p38 MAP kinase |
| Q44563635 | Indole-based heterocyclic inhibitors of p38alpha MAP kinase: designing a conformationally restricted analogue |
| Q35911103 | Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis |
| Q74257768 | Monitor: molecules and profiles |
| Q34502720 | Pharmacological inhibitors of MAPK pathways. |
| Q47121794 | Research advances in kinase enzymes and inhibitors for cardiovascular disease treatment. |
| Q79236264 | SAR of 3,4-Dihydropyrido[3,2-d]pyrimidone p38 inhibitors |
| Q35140855 | Therapeutic strategies for rheumatoid arthritis |
| Q44249286 | p38MAP kinase inhibitors. Part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold |
Search more.